您的位置: 首页 > 资讯

Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year

2024-06-03 来源:European Academy of Allergy and Clinical Immunology

The HEAD registry, with nearly 800 patients, serves to evaluate the economic and social impact of allergies at a European level

 

The HEAD registry, with nearly 800 patients, serves to evaluate the economic and social impact of allergies at a European level

VALENCIA, Spain, June 02, 2024 (GLOBE NEWSWIRE) -- Allergic diseases cost between 1,823€ and 6,656€ per patient per year if we only consider the direct costs derived from healthcare, according to a study of the data collected through the European HEAD registry promoted by the EAACI, which is holding its congress at the Feria de Valencia until Monday, June 3.

Allergic diseases and asthma are among the most common chronic diseases worldwide and account for a considerable global health burden. However, their real impact is difficult to estimate due to the lack of representativeness and incompleteness of the available data,” explain Dr. Ioana Agache, who chairs EAACI's Research and Outreach Committee (ROC). The HEAD registry was launched to describe patterns of care for allergic diseases and asthma and to assess their impact on costs, both financial and personal. On average, adult patients lost between 2.68 and 5.33 days of work, children between 14.88 and 24.09 days of school and their families between 3.99 and 23.35 days.

The significant burden of allergic diseases, according to this research, calls for immediate action to improve their management,” says Dr. Agache. “Treatments advised by EAACI guidelines can improve outcomes, but global clean air measures are needed to make a significant impact,” she points out.

The Congress also discusses how to facilitate the translation of trial and research results into routine clinical practice. “There are some experimental approaches with greater potential to be translated to the clinic, such as flow cytometry for basophil activation tests or ELISA to measure periostin levels,” explains María Escribese Alonso, Vice-Dean of Research at the Faculty of Medicine of the CEU San Pablo University and director of the Institute of Applied Molecular Medicine-Nemesio Diez. She also stresses that Spain is a great country for translational research in allergy “promoting networks where clinicians and researchers have the opportunity to collaborate with a common goal.”

Press Contact EAACI
+41 44 205 55 33
communications@eaaci.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/10adb810-ecda-4f52-aa8c-445a31170caa

01-16 Sendai Isawa Family Katsuyama Sake Brewery: SAMURAI SAKE: Reviving a 300-Year-Old Recipe
Sendai Isawa Family Katsuyama Sake Brewery: SAMURAI SAKE: Reviving a 300-Year-Old Recipe
“RYOAN LEGEND 2012 Junmai Daiginjo-DOUBLE UMAMI FINISH - Um [详细]
12-06 于适三部作品获精神文明建设“五个一工程”优秀作品奖 好演员就是要用作品说话
于适三部作品获精神文明建设“五个一工程”优秀作品奖 好演员就是要用作品说话
近日,于适一身利落简约黑色西装亮相DIOR活动,一出场就成为现场瞩目 [详细]
09-23 奔赴双城,再创浪漫 2024年三亚婚庆产业推介活动圆满收官
奔赴双城,再创浪漫  2024年三亚婚庆产业推介活动圆满收官
2024年9月2日至6日,由三亚市旅文局主办,三亚市婚庆旅游行业协会承 [详细]
05-17 Brightcove连续第三年被《2024年The Aragon Research Globe企业视频》报告评为领导者
Brightcove连续第三年被《2024年The Aragon Research Globe企业视频》报告评为领导者
全球最值得信赖的流媒体技术公司Brightcove (Nasdaq: BCOV)连续 [详细]